This was my estimate on 11 April and IMO it is well within CSL reach. Since this note there has been confirmation that improvement on the margin due to lower plasma cost is happening too. I have seen estimates of around $12.30 EPS for FY 2025 floating around.
These estimates are based on fundamental on taking into account company activities as at today and planed future. I find it difficult to go by charts which doesn’t take any of the current development within the company into consideration. That is my two cents.
This was my estimate on 11 April and IMO it is well within CSL...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$282.30 |
Change
-4.000(1.40%) |
Mkt cap ! $136.3B | |||
| Open | High | Low | Value | Volume |
| $284.55 | $285.49 | $281.60 | $109.8M | 388.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1182 | $310.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $254.07 | 14070 | 2 |
View Market Depth
| Last trade - 15.59pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$282.15 |
Change
-4.000 ( 1.14 %) |
||||
| Open | High | Low | Volume | ||
| $284.55 | $285.49 | $281.60 | 22078 | ||
| Last updated 15.59pm 12/06/2024 ? | |||||
| CSL (ASX) Chart |